A novel method for closing the percutaneous transapical access tract using coils and gelatin matrix.
A patient with a symptomatic mitral paravalvular leak was successfully treated by implantation of an Amplatzer (16 mm) occluder device (AGA Medical, Plymouth, Minnesota) at the defect via percutaneous direct transapical puncture of the left ventricle. We describe a novel technique for closure and immediate hemostasis of the transapical access tract, comprising two stainless steel coils deployed across the myocardial wound and a hemostatic matrix injected at the epicardium and within the subcutaneous tract.
Department of Interventional and Structural Heart Disease, Lenox Hill Heart and Vascular Institute of New York, New York 10075, USA
Claudia A
CA
Martinez
Robert
R
Rosen
Howard
H
Cohen
Carlos E
CE
Ruiz
D006328:Cardiac Catheterization; D005260:Female; D005781:Gelatin Sponge, Absorbable / Q000627:therapeutic use*; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000601:surgery*; D055989:Septal Occluder Device; D013193:Stainless Steel
C411004:FloSeal Matrix; D013193:Stainless Steel